Search

Search Constraints

You searched for: Author/Creator Christoulas, Dimitrios

Search Results

1. Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: A report of the Greek myeloma study group in 97 patients. Issue 8 (12th May 2014)

2. Combination therapy of deferasirox and deferoxamine shows significant improvements in markers of iron overload in a patient with β‐thalassemia major and severe iron burden. Issue 3 (9th July 2013)

3. Consolidation therapy with the combination of bortezomib and lenalidomide (VR) without dexamethasone in multiple myeloma patients after transplant: Effects on survival and bone outcomes in the absence of bisphosphonates. Issue 4 (10th January 2019)

4. Denosumab effects on serum levels of the bone morphogenetic proteins antagonist noggin in patients with transfusion-dependent thalassemia and osteoporosis. Issue 1 (1st January 2019)

5. Effect of induction therapy with lenalidomide, doxorubicin and dexamethasone on bone remodeling and angiogenesis in newly diagnosed multiple myeloma. Issue 2 (22nd January 2019)

6. Evaluation of bone involvement in patients with Gaucher disease: a semi‐quantitative magnetic resonance imaging method (using ROI estimation of bone lesion) as an alternative method to semi‐quantitative methods used so far. (23rd March 2015)

7. Lenalidomide with low- or intermediate-dose dexamethasone in patients with relapsed or refractory myeloma. Issue 8 (2nd August 2016)

8. Low Bone Mineral Density and High Bone Turnover in Patients With Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study. Issue 6 (December 2019)

9. Pregnancy in beta‐thalassemia intermedia: 20‐year experience of a Greek thalassemia center. (26th June 2014)